Agromino A/S financials
Agromino A/S
549300KD26MLUOWM9D24 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | $53.9M | $35.6M |
| Other income | $749.0K | $91.0K |
| Administrative expenses | $1.7M | $1.6M |
| Employee benefits expense | $5.7M | $5.7M |
| Raw materials & consumables used | $38.2M | $29.8M |
| Depreciation & amortisation | $6.6M | $5.9M |
| Operating profit (EBIT) | -$2.8M | -$6.3M |
| Finance costs | $5.9M | $3.8M |
| Profit before tax | -$8.8M | -$12.8M |
| Income tax expense | $245.0K | $144.0K |
| Profit for the year | -$9.0M | -$12.9M |
| — attributable to owners | -$9.0M | -$12.9M |
| — attributable to NCI | $0 | $0 |
| Total comprehensive income | -$10.5M | -$20.3M |
| Cash flow statement | ||
| Net cash from operating activities | $9.1M | -$8.8M |
| Income taxes paid | $153.0K | $94.0K |
| Net cash from investing activities | -$5.9M | $627.0K |
| Purchase of PP&E (capex) | $6.0M | $1.5M |
| Net cash from financing activities | -$3.6M | $6.4M |
| Proceeds from borrowings | $21.1M | $22.0M |
| Repayments of borrowings | $14.7M | $9.6M |
| Net change in cash | -$508.0K | -$1.7M |
| Balance sheet | ||
| Total assets | $106.8M | $103.8M |
| Non-current assets | $61.1M | $52.2M |
| Property, plant & equipment | $20.8M | $19.0M |
| Right-of-use assets | $19.5M | $19.4M |
| Intangible assets & goodwill | $11.3M | $11.4M |
| Current assets | $45.7M | $51.6M |
| Inventories | $26.1M | $31.3M |
| Trade & other receivables | $13.7M | $14.5M |
| Cash & equivalents | $278.0K | $695.0K |
| Total equity | $56.5M | $66.9M |
| — attributable to owners | $56.5M | $66.9M |
| Non-controlling interests | -$30.0K | -$29.0K |
| Non-current liabilities | $17.5M | $15.1M |
| Long-term borrowings | $1.7M | $1.6M |
| Lease liabilities (non-current) | $14.6M | $13.5M |
| Current liabilities | $32.9M | $21.8M |
| Short-term borrowings | $19.3M | $13.3M |
| Lease liabilities (current) | $3.9M | $3.0M |
| Trade & other payables | $9.0M | $5.5M |
| Deferred tax liabilities | $36.0K | $42.0K |
| Derived metrics | ||
| Free cash flow | $3.1M | -$10.3M |
| Operating margin | -5.2% | -17.6% |
| Net margin | -16.7% | -36.1% |
| Return on equity | -16.0% | -19.2% |
| Cash conversion ratio | -1.01× | 0.68× |
| Capex coverage | 1.52× | -5.89× |
| Other reported items | ||
| Cash and Cash Equivalents Classified As Part of Disposal Group Held For Sale | $0 | $0 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $0 | $2.1M |
| Changes In Inventories of Finished Goods and Work In Progress | $3.0M | -$7.5M |
| Comprehensive Income Attributable To Noncontrolling Interests | $0 | $0 |
| Comprehensive Income Attributable To Owners of Parent | -$10.5M | -$20.3M |
| Cost of Merchandise Sold | $2.7M | $1.6M |
| Current Biological Assets | $5.6M | $5.1M |
| Current Deferred Income Including Current Contract Liabilities | $651.0K | $0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $91.0K | $950.0K |
| Equity and Liabilities | $106.8M | $103.8M |
| Finance Income | $443.0K | $155.0K |
| Gains Losses On Exchange Differences On Translation Net of Tax | -$1.4M | -$17.9M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$506.0K | -$2.9M |
| Gains Losses On Fair Value Adjustment Biological Assets | $797.0K | $4.4M |
| Interest Paid Classified As Financing Activities | $1.9M | $549.0K |
| Interest Received Classified As Operating Activities | $61.0K | $21.0K |
| Issued Capital | $8.7M | $8.7M |
| Liabilities | $50.4M | $36.9M |
| Noncurrent Biological Assets | $741.0K | $735.0K |
| Noncurrent Deferred Income Including Noncurrent Contract Liabilities | $971.0K | — |
| Noncurrent Lease Prepayments | $130.0K | $160.0K |
| Noncurrent Payables | $223.0K | $4.0K |
| Other Comprehensive Income | -$1.4M | -$7.4M |
| Other Comprehensive Income Net of Tax Gains Losses On Revaluation | $0 | $0 |
| Other Gains Losses | -$341.0K | -$9.2M |
| Other Inflows Outflows of Cash Classified As Financing Activities | $96.0K | $299.0K |
| Other Reserves | -$60.7M | -$59.3M |
| Payments To Suppliers For Goods and Services and To and On Behalf of Employees | $46.6M | $45.5M |
| Proceeds From Issuing Shares | — | $0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $30.0K | $54.0K |
| Profit Loss From Continuing Operations | -$9.0M | -$12.9M |
| Profit Loss From Discontinued Operations | $0 | $61.0K |
| Receipts From Sales of Goods and Rendering of Services | $55.1M | $36.8M |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | $0 | -$10.5M |
| Retained Earnings | $16.2M | $25.3M |
| Share Premium | $92.3M | $92.3M |
Every line item above is a fact tagged in Agromino A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.